Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 23 INDUSTRY 22 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 74 Head & Neck 16 Breast 11 Gynecologic 5 Genitourinary 5 Tumor-Agnostic 1 Thoracic 1 Dermatologic 1

Conditions

Neoplasm Metastasis 1

Interventions

regorafenib 2 Radiotherapy 2 Music Therapy 2 Interviews as Topic 2 Albumin-Bound Paclitaxel 2 trifluridine tipiracil drug combination 1 tremelimumab 1 plozalizumab 1 pegfilgrastim 1 nintedanib 1 merphos 1 durvalumab 1 cabozantinib 1 Vinblastine 1 Trifluridine 1 Surveys and Questionnaires 1 Standard of Care 1 Spermine Synthase 1 Radiosurgery 1 Psychiatrists 1 Psychiatric Rehabilitation 1 Proton Therapy 1 Prednisone 1 Practice Guidelines as Topic 1 Platinum 1 Paclitaxel 1 Oxycodone 1 Oxaliplatin 1 Olanzapine 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Fluorouracil × Tumor-Agnostic × Clear all

NCT02856867 2017-05-09

MEGAN

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡